Differences in the Course of depression and anxiety After COVID-19 Infection Between Recovered Patients With and Without a Psychiatric History: A Cross-Sectional Study DOI Open Access
Megumi Hazumi, Kentaro Usuda, Emi Okazaki

и другие.

Опубликована: Авг. 12, 2022

Background: This study aimed to examine the course of Depression and anxiety in COVID-19 survivors with a psychiatric history compared those without history. Methods: A web-based cross-sectional survey for was conducted from July September 2021. 6016 survivors, accuracy whose responses determined be assured, were included analyses. Exposures time since infection, main outcomes measures severity depression anxiety, as assessed using Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7), respectively. Results: Mean PHQ-9 GAD-7 significantly higher participants than Two-way analysis covariance showed significant effect presence interaction × infection. score revealed infection these factors. Conclusions: The more severe

Язык: Английский

Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches DOI Creative Commons
Rasha Ashmawy, Esraa Abdellatif Hammouda, Yousra A. El‐Maradny

и другие.

Biomolecules, Год журнала: 2024, Номер 14(7), С. 835 - 835

Опубликована: Июль 11, 2024

Long COVID, a name often given to the persistent symptoms following acute SARS-CoV-2 infection, poses multifaceted challenge for health. This review explores intrinsic relationship between comorbidities and autoimmune responses in shaping trajectory of long COVID. Autoantibodies have emerged as significant players COVID-19 pathophysiology, with implications disease severity progression. Studies show immune dysregulation persisting months after marked by activated innate cells high cytokine levels. The presence autoantibodies against various autoantigens suggests their potential comorbid factors Additionally, formation complexes may lead severe progression, highlighting urgency early detection intervention. Furthermore, COVID is highly linked cardiovascular complications neurological symptoms, posing challenges diagnosis management. Multidisciplinary approaches, including vaccination, tailored rehabilitation, pharmacological interventions, are used mitigating COVID’s burden. However, numerous persist, from evolving diagnostic criteria addressing psychosocial impact predicting outcomes. Leveraging AI-based applications holds promise enhancing patient management improving our understanding As research continues unfold, unravelling complexities remains paramount effective intervention care.

Язык: Английский

Процитировано

11

Three-Month Follow-Up of the Post-COVID Syndrome after Admission to a Specialised Post-COVID Centre—A Prospective Study Focusing on Mental Health with Patient Reported Outcome Measures (PROMs) DOI Open Access

Isabel Cecil Schäfer,

Johannes Krehbiel,

Werner Adler

и другие.

International Journal of Environmental Research and Public Health, Год журнала: 2024, Номер 21(8), С. 1076 - 1076

Опубликована: Авг. 16, 2024

Background and objective: The impairments duration of PASC (post-acute sequelae COVID-19) symptoms in mental health have, to date, not been comprehensively examined. Our objective is provide longitudinal data on the Post-COVID patients identify risk protective factors associated with a severe or prolonged course. Methods: 265 outpatient centre University Hospital Erlangen was assessed 17.1 (T0) 22.5 months after infection (T1). An online survey validated questionnaires for (Post-COVID Syndrome Score), depression (Patient Health Questionnaire-9), somatic Questionnaire-15), anxiety (Generalized Anxiety Disorder-7), fatigue (Fatigue Severity Scale) Post-Exertional Malaise (PEM) (DePaul Screening) conducted home environment. Results: In total, 80% experienced at follow-up. Clinically relevant depression, persistent symptoms, were reported by 55.8%, 72.5%, 18.9% 89.4% patients, respectively. Depressive, symptom severity decreased significantly over time; PEM remained an unchanged high level. factor higher scores older age; prior psychiatric illness treated psychotherapy more depressive, somatic, symptoms. longer between acute initial presentation centre. Conclusions: findings align previous research, claiming syndrome, lasting infection. In-depth assessment implications needed planning services disease prevention.

Язык: Английский

Процитировано

1

Differences in the Course of depression and anxiety After COVID-19 Infection Between Recovered Patients With and Without a Psychiatric History: A Cross-Sectional Study DOI Open Access
Megumi Hazumi, Kentaro Usuda, Emi Okazaki

и другие.

Опубликована: Авг. 12, 2022

Background: This study aimed to examine the course of Depression and anxiety in COVID-19 survivors with a psychiatric history compared those without history. Methods: A web-based cross-sectional survey for was conducted from July September 2021. 6016 survivors, accuracy whose responses determined be assured, were included analyses. Exposures time since infection, main outcomes measures severity depression anxiety, as assessed using Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7), respectively. Results: Mean PHQ-9 GAD-7 significantly higher participants than Two-way analysis covariance showed significant effect presence interaction × infection. score revealed infection these factors. Conclusions: The more severe

Язык: Английский

Процитировано

3